THE CHINWAGY BUZZ · FIRST VERIFIED WORD
Takeda enters global oncology partnership with Innovent Biologics
WHAT CHINWAGY KNOWS
The collaboration
is confirmed.
Takeda entered a license and collaboration agreement with Innovent Biologics for development, manufacturing and commercialization of two late-stage oncology medicines worldwide outside Greater China, with an additional option for an early-stage program.
- Current status
- Official collaboration
- Known availability
- Started 2025-10-21; the official source does not state an end date.
- Place
- International, Global excluding Greater China
- Source checked
- September 8, 2026
FOLLOW THE STORY